COSCIENS Biopharma Inc. (LON:0UGB)
4.200
-0.050 (-1.18%)
At close: Jan 22, 2025
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of 6.1 million as of November 6, 2025. Its market cap has decreased by -47.14% in one year.
Market Cap
6.10M
Enterprise Value
857.51K
Revenue
6.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.20
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 7.20B to 6.10M, a decrease of -99.92%. That is a compound annual growth rate of -21.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 6.10M | 58.68% |
| Dec 31, 2024 | 3.84M | -48.21% |
| Dec 29, 2023 | 7.42M | -42.06% |
| Dec 30, 2022 | 12.80M | -60.28% |
| Dec 31, 2021 | 32.23M | 65.68% |
| Dec 31, 2020 | 19.46M | 40.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.27B |
| HSBC Holdings | 184.59B |
| Shell | 164.07B |
| Unilever | 115.32B |
| Rolls-Royce Holdings | 96.56B |
| Rio Tinto Group | 90.02B |
| British American Tobacco p.l.c. | 88.16B |
| GSK plc | 71.94B |